Study of AFP464 +/- Faslodex in ER + Breast Cancer

Clinical trial NCT01233947 · TERMINATED

Trial details

NCT number: NCT01233947
Sponsor: Tigris Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm

Start date: 2011-05-01
Primary completion: 2012-08-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.